CTMX

CytomX Therapeutics, Inc. - Common Stock (CTMX)

About CytomX Therapeutics, Inc. - Common Stock (CTMX)

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Details

Daily high

$2.29

Daily low

$2.03

Price at open

$2.06

52 Week High

$2.55

52 Week Low

$0.40

Market cap

351.3M

Dividend yield

0.00%

Volume

3.1M

Avg. volume

11.2M

P/E ratio

4.50

CytomX Therapeutics, Inc. - Common Stock News